Macular phototoxicity after corneal cross-linking

Paulo Rodolfo Tagliari Barbisan,1 Marina Gonçalves Monteiro Viturino,1 Fernanda Maria Silveira Souto,1 Bo Tian,2,3 Roberto Damian Pacheco Pinto,1 Lucas Barasnevicius Quagliato,1 Maurício Abujamra Nascimento,1 Rosane Silvestre de Castro,1 Carlos Eduardo Leite Arieta1 1Departmen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Barbisan PRT, Viturino MGM, Souto FMS, Tian B, Pinto RD, Quagliato LB, Nascimento MA, de Castro RS, Arieta CEL
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/214f3fb3b09d4b66964e6452675ffcef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:214f3fb3b09d4b66964e6452675ffcef
record_format dspace
spelling oai:doaj.org-article:214f3fb3b09d4b66964e6452675ffcef2021-12-02T02:37:04ZMacular phototoxicity after corneal cross-linking1177-5483https://doaj.org/article/214f3fb3b09d4b66964e6452675ffcef2018-09-01T00:00:00Zhttps://www.dovepress.com/macular-phototoxicity-after-corneal-cross-linking-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Paulo Rodolfo Tagliari Barbisan,1 Marina Gonçalves Monteiro Viturino,1 Fernanda Maria Silveira Souto,1 Bo Tian,2,3 Roberto Damian Pacheco Pinto,1 Lucas Barasnevicius Quagliato,1 Maurício Abujamra Nascimento,1 Rosane Silvestre de Castro,1 Carlos Eduardo Leite Arieta1 1Department of Ophthalmology, State University of Campinas, Campinas, São Paulo, Brazil; 2Angiogenesis Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA; 3Department of Ophthalmology and Visual Sciences, University of Massachusetts Medical School, Worcester, MA, USA Purpose: To assess potential vascular, structural, and functional changes to the macula in patients with keratoconus that underwent ultraviolet A (UVA)–riboflavin-mediated corneal collagen cross-linking (CXL) therapy.Patients and methods: Seventeen eyes from 17 patients of age 16 years or older with keratoconus undergoing CXL treatment were studied. The same eye served as its own control (before CXL vs after CXL). Eyes were evaluated in terms of best-corrected visual acuity (BCVA), refractive error, intraocular pressure, Amsler grid, retinography, fluorescein angiography, autofluorescence, and spectral domain optical coherence tomography (SD-OCT) prior to CXL and 7 and 30 days after treatment. Multifocal electroretinography (mfERG) was recorded prior to and 7 days after CXL.Results: Mean (SD) BCVA by logMAR chart was 0.47 (±0.12) pre-CXL, 0.55 (±0.15) 7 days post-CXL (P=0.57), and 0.46 (±0.10) 30 days post-CXL (P=0.87). Mean (SD) SD-OCT central macular thickness (µm) was 253.62 (±20.9) pre-CXL, 260.5 (±18.7) 7 days post-CXL (P=0.48), and 256.44 (±21.6) 30 days post-CXL (P=0.69). In 12 eyes, mfERG revealed a statistically significant increase (P=0.0353) in P1 latency (ms) of ring four from the pre-CXL period (39.45±2.05) to 7 days post-CXL (41.04±1.28) period. Regression analysis showed that the increase in P1 latency was correlated with the increase in central macular thickness (P=0.027). Furthermore, nine patients experienced a significant decrease in P1 amplitudes of rings 1 (P=0.0014), 2 (P=0.0029), 3 (P=0.0037), 4 (P=0.0014), and 5 (P=0.0012) from pre-CXL to 7 days post-CXL.Conclusion: In this pilot study, most of the patients exhibited slight changes in their mfERG parameters and OCT thickness, despite a lack of vascular abnormalities observed on fluorescein angiography/autofluorescence imaging, no alteration in BCVA, and no reports of symptoms. These changes could, therefore, be categorized as a mild subclinical effect of the corneal cross-linking procedure. Keywords: keratoconus, light damage, multifocal electroretinogram, UVA, phototoxicity, crosslinkingBarbisan PRTViturino MGMSouto FMSTian BPinto RDQuagliato LBNascimento MAde Castro RSArieta CELDove Medical Pressarticlekeratoconuslight damagemultifocal electroretinogramUVA.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 1801-1807 (2018)
institution DOAJ
collection DOAJ
language EN
topic keratoconus
light damage
multifocal electroretinogram
UVA.
Ophthalmology
RE1-994
spellingShingle keratoconus
light damage
multifocal electroretinogram
UVA.
Ophthalmology
RE1-994
Barbisan PRT
Viturino MGM
Souto FMS
Tian B
Pinto RD
Quagliato LB
Nascimento MA
de Castro RS
Arieta CEL
Macular phototoxicity after corneal cross-linking
description Paulo Rodolfo Tagliari Barbisan,1 Marina Gonçalves Monteiro Viturino,1 Fernanda Maria Silveira Souto,1 Bo Tian,2,3 Roberto Damian Pacheco Pinto,1 Lucas Barasnevicius Quagliato,1 Maurício Abujamra Nascimento,1 Rosane Silvestre de Castro,1 Carlos Eduardo Leite Arieta1 1Department of Ophthalmology, State University of Campinas, Campinas, São Paulo, Brazil; 2Angiogenesis Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA; 3Department of Ophthalmology and Visual Sciences, University of Massachusetts Medical School, Worcester, MA, USA Purpose: To assess potential vascular, structural, and functional changes to the macula in patients with keratoconus that underwent ultraviolet A (UVA)–riboflavin-mediated corneal collagen cross-linking (CXL) therapy.Patients and methods: Seventeen eyes from 17 patients of age 16 years or older with keratoconus undergoing CXL treatment were studied. The same eye served as its own control (before CXL vs after CXL). Eyes were evaluated in terms of best-corrected visual acuity (BCVA), refractive error, intraocular pressure, Amsler grid, retinography, fluorescein angiography, autofluorescence, and spectral domain optical coherence tomography (SD-OCT) prior to CXL and 7 and 30 days after treatment. Multifocal electroretinography (mfERG) was recorded prior to and 7 days after CXL.Results: Mean (SD) BCVA by logMAR chart was 0.47 (±0.12) pre-CXL, 0.55 (±0.15) 7 days post-CXL (P=0.57), and 0.46 (±0.10) 30 days post-CXL (P=0.87). Mean (SD) SD-OCT central macular thickness (µm) was 253.62 (±20.9) pre-CXL, 260.5 (±18.7) 7 days post-CXL (P=0.48), and 256.44 (±21.6) 30 days post-CXL (P=0.69). In 12 eyes, mfERG revealed a statistically significant increase (P=0.0353) in P1 latency (ms) of ring four from the pre-CXL period (39.45±2.05) to 7 days post-CXL (41.04±1.28) period. Regression analysis showed that the increase in P1 latency was correlated with the increase in central macular thickness (P=0.027). Furthermore, nine patients experienced a significant decrease in P1 amplitudes of rings 1 (P=0.0014), 2 (P=0.0029), 3 (P=0.0037), 4 (P=0.0014), and 5 (P=0.0012) from pre-CXL to 7 days post-CXL.Conclusion: In this pilot study, most of the patients exhibited slight changes in their mfERG parameters and OCT thickness, despite a lack of vascular abnormalities observed on fluorescein angiography/autofluorescence imaging, no alteration in BCVA, and no reports of symptoms. These changes could, therefore, be categorized as a mild subclinical effect of the corneal cross-linking procedure. Keywords: keratoconus, light damage, multifocal electroretinogram, UVA, phototoxicity, crosslinking
format article
author Barbisan PRT
Viturino MGM
Souto FMS
Tian B
Pinto RD
Quagliato LB
Nascimento MA
de Castro RS
Arieta CEL
author_facet Barbisan PRT
Viturino MGM
Souto FMS
Tian B
Pinto RD
Quagliato LB
Nascimento MA
de Castro RS
Arieta CEL
author_sort Barbisan PRT
title Macular phototoxicity after corneal cross-linking
title_short Macular phototoxicity after corneal cross-linking
title_full Macular phototoxicity after corneal cross-linking
title_fullStr Macular phototoxicity after corneal cross-linking
title_full_unstemmed Macular phototoxicity after corneal cross-linking
title_sort macular phototoxicity after corneal cross-linking
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/214f3fb3b09d4b66964e6452675ffcef
work_keys_str_mv AT barbisanprt macularphototoxicityaftercornealcrosslinking
AT viturinomgm macularphototoxicityaftercornealcrosslinking
AT soutofms macularphototoxicityaftercornealcrosslinking
AT tianb macularphototoxicityaftercornealcrosslinking
AT pintord macularphototoxicityaftercornealcrosslinking
AT quagliatolb macularphototoxicityaftercornealcrosslinking
AT nascimentoma macularphototoxicityaftercornealcrosslinking
AT decastrors macularphototoxicityaftercornealcrosslinking
AT arietacel macularphototoxicityaftercornealcrosslinking
_version_ 1718402333799350272